US Stock MarketDetailed Quotes

SLDB Solid Biosciences

Watchlist
  • 9.0550
  • -0.4450-4.68%
Trading Jul 30 12:23 ET
347.53MMarket Cap-2304P/E (TTM)

Solid Biosciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
-40.57%8.09M
0
0
71.65%6.17M
Operating revenue
--0
--0
--0
--0
--0
--0
-40.57%8.09M
--0
--0
71.65%6.17M
Cost of revenue
Gross profit
Operating expense
-16.13%26.86M
-2.84%104.32M
-22.98%22.27M
9.38%23.11M
-10.41%26.91M
17.34%32.03M
25.03%107.37M
32.57%28.91M
-2.02%21.13M
34.80%30.03M
Selling and administrative expenses
7.97%7.99M
-4.13%27.75M
-10.58%6.81M
-10.03%6.41M
4.06%7.13M
0.64%7.4M
6.68%28.95M
5.64%7.62M
-0.22%7.13M
1.26%6.85M
-General and administrative expense
7.97%7.99M
-4.13%27.75M
-10.58%6.81M
-10.03%6.41M
4.06%7.13M
0.64%7.4M
6.68%28.95M
5.64%7.62M
-0.22%7.13M
1.26%6.85M
Research and development costs
-23.38%18.87M
-2.37%76.56M
-27.42%15.45M
19.26%16.7M
-14.68%19.78M
23.49%24.63M
33.51%78.42M
45.87%21.29M
-2.91%14.01M
49.42%23.18M
Operating profit
16.13%-26.86M
-5.08%-104.32M
22.98%-22.27M
-9.38%-23.11M
-12.76%-26.91M
-26.24%-32.03M
-37.40%-99.27M
-54.99%-28.91M
-17.20%-21.13M
-27.71%-23.86M
Net non-operating interest income expense
52.32%2.56M
173.01%7.14M
8.15%1.66M
152.52%1.86M
565.19%1.95M
3,007.41%1.68M
3,987.50%2.62M
1.53M
735K
293K
Non-operating interest income
47.36%2.65M
173.01%7.14M
8.15%1.66M
152.52%1.86M
565.19%1.95M
--1.8M
3,987.50%2.62M
--1.53M
--735K
--293K
Non-operating interest expense
-21.49%95K
----
----
----
----
--121K
----
----
----
----
Other net income (expense)
-98.94%3K
-89.15%1.16M
-97.79%270K
2,238.46%278K
121.54%328K
2,920.00%282K
533,750.00%10.68M
55,659.09%12.22M
-127.08%-13K
-15,130.00%-1.52M
Special income (charges)
----
-99.43%63K
--0
--0
104.14%63K
----
--11.06M
--12.58M
--0
---1.52M
-Less:Restructuring and merger&acquisition
----
99.43%-63K
--0
--0
-104.14%-63K
----
---11.06M
---12.58M
--0
--1.52M
Other non- operating income (expenses)
-98.94%3K
387.40%1.1M
176.06%270K
2,238.46%278K
8,933.33%265K
2,920.00%282K
-19,150.00%-381K
-1,513.64%-355K
-127.08%-13K
70.00%-3K
Income before tax
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
Income tax
Net income
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
Net income continuous Operations
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
Minority interest income
Net income attributable to the parent company
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.18%-24.3M
-11.67%-96.02M
-34.22%-20.34M
-2.79%-20.98M
1.85%-24.63M
-18.72%-30.07M
-19.11%-85.98M
18.59%-15.15M
-13.50%-20.41M
-34.22%-25.09M
Basic earnings per share
58.44%-0.64
52.18%-4.83
-47.06%-1
61.25%-1.05
62.46%-1.25
54.30%-1.54
0.39%-10.1
72.31%-0.68
-12.86%-2.71
-30.59%-3.33
Diluted earnings per share
58.44%-0.64
52.18%-4.83
-47.06%-1
61.25%-1.05
62.46%-1.25
54.30%-1.54
0.39%-10.1
72.31%-0.68
-12.86%-2.71
-30.59%-3.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 000000-40.57%8.09M0071.65%6.17M
Operating revenue --0--0--0--0--0--0-40.57%8.09M--0--071.65%6.17M
Cost of revenue
Gross profit
Operating expense -16.13%26.86M-2.84%104.32M-22.98%22.27M9.38%23.11M-10.41%26.91M17.34%32.03M25.03%107.37M32.57%28.91M-2.02%21.13M34.80%30.03M
Selling and administrative expenses 7.97%7.99M-4.13%27.75M-10.58%6.81M-10.03%6.41M4.06%7.13M0.64%7.4M6.68%28.95M5.64%7.62M-0.22%7.13M1.26%6.85M
-General and administrative expense 7.97%7.99M-4.13%27.75M-10.58%6.81M-10.03%6.41M4.06%7.13M0.64%7.4M6.68%28.95M5.64%7.62M-0.22%7.13M1.26%6.85M
Research and development costs -23.38%18.87M-2.37%76.56M-27.42%15.45M19.26%16.7M-14.68%19.78M23.49%24.63M33.51%78.42M45.87%21.29M-2.91%14.01M49.42%23.18M
Operating profit 16.13%-26.86M-5.08%-104.32M22.98%-22.27M-9.38%-23.11M-12.76%-26.91M-26.24%-32.03M-37.40%-99.27M-54.99%-28.91M-17.20%-21.13M-27.71%-23.86M
Net non-operating interest income expense 52.32%2.56M173.01%7.14M8.15%1.66M152.52%1.86M565.19%1.95M3,007.41%1.68M3,987.50%2.62M1.53M735K293K
Non-operating interest income 47.36%2.65M173.01%7.14M8.15%1.66M152.52%1.86M565.19%1.95M--1.8M3,987.50%2.62M--1.53M--735K--293K
Non-operating interest expense -21.49%95K------------------121K----------------
Other net income (expense) -98.94%3K-89.15%1.16M-97.79%270K2,238.46%278K121.54%328K2,920.00%282K533,750.00%10.68M55,659.09%12.22M-127.08%-13K-15,130.00%-1.52M
Special income (charges) -----99.43%63K--0--0104.14%63K------11.06M--12.58M--0---1.52M
-Less:Restructuring and merger&acquisition ----99.43%-63K--0--0-104.14%-63K-------11.06M---12.58M--0--1.52M
Other non- operating income (expenses) -98.94%3K387.40%1.1M176.06%270K2,238.46%278K8,933.33%265K2,920.00%282K-19,150.00%-381K-1,513.64%-355K-127.08%-13K70.00%-3K
Income before tax 19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M-34.22%-25.09M
Income tax
Net income 19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M-34.22%-25.09M
Net income continuous Operations 19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M-34.22%-25.09M
Minority interest income
Net income attributable to the parent company 19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M-34.22%-25.09M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.18%-24.3M-11.67%-96.02M-34.22%-20.34M-2.79%-20.98M1.85%-24.63M-18.72%-30.07M-19.11%-85.98M18.59%-15.15M-13.50%-20.41M-34.22%-25.09M
Basic earnings per share 58.44%-0.6452.18%-4.83-47.06%-161.25%-1.0562.46%-1.2554.30%-1.540.39%-10.172.31%-0.68-12.86%-2.71-30.59%-3.33
Diluted earnings per share 58.44%-0.6452.18%-4.83-47.06%-161.25%-1.0562.46%-1.2554.30%-1.540.39%-10.172.31%-0.68-12.86%-2.71-30.59%-3.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg